About Scinopsis
Scinopsis is a company based in Frejus (France) founded in 2006 by Helen Baldwin was acquired by Veristat in June 2023. Scinopsis offers products and services including Medical Writing, Regulatory Consulting, and Clinical Operations. Scinopsis operates in a competitive market with competitors including Soterius, SFL Regulatory Affairs & Scientific Communication, InfocusRx, Regulatory Professionals and AxPharma, among others.
- Headquarter Frejus, France
- Founders Helen Baldwin
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Veristat, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scinopsis
Scinopsis offers a comprehensive portfolio of products and services, including Medical Writing, Regulatory Consulting, and Clinical Operations.
Creates regulatory documents for drug development processes.
Provides advice on regulatory submissions and compliance.
Manages project and site monitoring for trials.
Funding Insights of Scinopsis
Detailed funding history for Scinopsis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Scinopsis
Scinopsis has secured backing from 1 investor. Prominent investors backing the company include Veristat.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical trials and regulatory submissions are supported as a CRO.
|
Locked | Locked | Locked |
Investor details for Scinopsis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scinopsis
Investment portfolio details for Scinopsis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scinopsis
Detailed financials for Scinopsis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scinopsis Comparisons
Peer comparison for Scinopsis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scinopsis
Scinopsis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Soterius, SFL Regulatory Affairs & Scientific Communication, InfocusRx, Regulatory Professionals and AxPharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance, medical affairs, and drug safety services are provided.
|
|
| Locked | Locked | Locked |
Consulting services in regulatory affairs and scientific communication are provided.
|
|
| Locked | Locked | Locked |
Offers branding, digital marketing, and knowledge services for healthcare industries.
|
|
| Locked | Locked | Locked |
Regulatory consulting services for medical writing and strategies are provided.
|
|
| Locked | Locked | Locked |
Provider of vigilance, case treatment, and medical writing services for life science companies
|
Detailed competitors of Scinopsis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scinopsis
Complete news archive for Scinopsis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scinopsis
Scinopsis was founded in 2006.
Scinopsis is headquartered in Frejus, France. It is registered at Frejus, Var, France.
The company was founded in 2006 in Frejus, France, where semiconductor and power electronic devices are produced. Products such as diodes, MOSFETs, integrated circuits, power modules, and conditioners are offered for applications in mobility, energy, industrial equipment, telecommunications, and home appliances. Development is directed toward energy efficiency improvements, gallium oxide devices, and contactless charging systems. Support services include FAQs, catalog downloads, and details on discontinued products.
Scinopsis's top competitors include Soterius, Regulatory Professionals and SFL Regulatory Affairs & Scientific Communication.
Scinopsis offers Medical Writing, Regulatory Consulting, and Clinical Operations.
Scinopsis has 1 investor. Key investors include Veristat.